Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Elemental-F Syrup is an oral haematinic formulation developed by Juggat Pharma (a division of Jagdale Industries). It is indicated for the management of iron deficiency anaemia, nutritional deficiencies, and for OB/GYN patient management, particularly during pregnancy and lactation. The syrup contains a comprehensive combination of ferrous glycine sulphate (a highly bioavailable source of iron), essential amino acids (L-histidine and L-lysine), B-vitamins (pyridoxine/vitamin B6, nicotinamide, and cyanocobalamin/vitamin B12), folic acid, and zinc ascorbate. This combination promotes red blood cell formation, enhances iron absorption, and supports overall blood health, wound healing, and cardiovascular health.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Elemental-F Syrup.